Related Experiment Video
Updated: May 16, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.3243A>G MTTL1 mutation
Henriette J Tschampa1, Horst Urbach, Susanne Greschus
1Department of Radiology (Neuroradiology), University of Bonn, Bonn, Germany. henriette.tschampa@ukb.uni-bonn.de
Abstract:
Stroke-like lesions (SLL) are common radiological findings in patients with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (SLE; MELAS) harboring the m.3243A>G MTTL1 mutation. Imaging patterns in the m.3243A>G mutation carriers with encephalopathies lacking SLE have not been systematically examined to date. The aim of this study was to analyze brain imaging findings in encephalopathies associated with the m.3243A>G mutation irrespective of the presence or absence of SLE. Brain MRI and cranial CT scans from 11 m.3243A>G mutation carriers with encephalopathies were analyzed by two neuroradiologists in consensus. We evaluated stroke-like lesions (SLL), deep grey matter (DGM) changes on T1- and T2-weighted MR images, calcification on CT, brain atrophy, and white matter (WM) changes. SLL were present in all patients showing the full MELAS phenotype with SLE (4/11). Seven patients did not show SLE. DGM changes with T1 hyperintensity and T2 hypointensity were a distinctive finding in most patients (7/11) and present in the majority of m.3243A>G mutation carriers lacking SLE (5/7). DGM changes were also seen in half of our MELAS patients with SLL (2/4), though less pronounced. Brain atrophy was a prominent finding in general and accentuated in the cerebellum. In contrast, WM changes were rather mild and more prevalent and pronounced in MELAS. Our data stress that the distinction between MELAS with SLE and m.3243A>G mutation carriers lacking SLE is rather artificial. In clinical practice, mitochondrial disorders associated with the m.3243A>G mutation should be taken into consideration in encephalopathies with DGM changes, even when SLE and SLL are lacking.
Insights
Deep grey matter changes are key indicators of mitochondrial encephalopathy in patients with the m.3243A>G mutation, even without stroke-like episodes or lesions. This finding aids in diagnosing mitochondrial disorders.
Area of Science:
- Neurology
- Radiology
- Genetics
Background:
- Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) typically presents with stroke-like lesions (SLL) in m.3243A>G mutation carriers.
- Imaging patterns in m.3243A>G mutation carriers without stroke-like episodes (SLE) are less understood.
Purpose of the Study:
- To analyze brain imaging findings in encephalopathies associated with the m.3243A>G mutation, regardless of SLE presence.
- To identify distinct imaging biomarkers for mitochondrial disorders.
Main Methods:
- Retrospective analysis of brain MRI and CT scans from 11 m.3243A>G mutation carriers.
- Evaluation of stroke-like lesions (SLL), deep grey matter (DGM) changes, calcification, atrophy, and white matter (WM) changes by consensus of two neuroradiologists.
Main Results:
- SLL were present in all patients with the full MELAS phenotype (4/11).
- Deep grey matter (DGM) changes (T1 hyperintensity, T2 hypointensity) were prominent in 7/11 patients, particularly those without SLE (5/7).
- Brain atrophy was common, especially in the cerebellum; WM changes were milder and more pronounced in MELAS patients.
Conclusions:
- The distinction between MELAS with SLE and m.3243A>G carriers without SLE may be artificial.
- Encephalopathies with DGM changes should prompt consideration of mitochondrial disorders linked to the m.3243A>G mutation, even without SLE or SLL.
